Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu"
Abstract
State University of Medicine and Pharmacy "Nicolae Testemitanu" Department of internal medicine, Cardiology, Chișinău, Republic of Moldova,
University Hospital Frankfurt, Cardiology Institute, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltareIntroduction Aortic stenosis (AS) is the most prevalent primary heart valve
disease and the third most prevalent cardiovascular disease in the world, having a
severe and slowly progressive evolution. The implementation of Transcatheter
Aortic Valve Implantation (TAVI) is necessary because the population is constantly
ageing, and most elderly people have various comorbidities, which places them
among patients with high surgical risk.Purpose Assessment TAVI effectiveness in the treatment of aortic valve stenosis.
Being the first team of doctors who performed TAVI in our country, we have the
opportunity to report the data of a series of cases, with clinical results at 9 months
after the procedure.
Material and methods
Three patients with severe symptomatic AS and high surgical risk underwent TAVI
implantation using Portico valves. The patients were tested with angio-CT and
echocardiography before de procedure.The procedure was done under fluoroscopic guidance and on the right are shown
the prosthetic valve delivery steps, (1)- . Balloon valvuloplasty of the native AoV, (2)-
Prosthetic valve positioning, (3)-Expanded prosthetic valve.Results The mean age was 76.7 ± 1.2 years, 2 women and 1 man.
The mean Logistic EuroSCORE II was 5.68 ± 0.67%. Procedural
success was achieved in all (100%) patients. After the intervention, it
was shown that the GP mean decreased by an average of 20.27±1.61
mmHg, the Vmax of the jet through AoV decreased on average by
2.05±0.19 m/s, and they were maintained all over the nine months
follow-up period (table 1). Quality of life, using the TASQ (Toronto
Aortic Stenosis Quality of Life) questionnaire, was improved by 62.3
± 2.2 points.Conclusions : TAVI, as a new minimally invasive method of
treatment for aortic valve stenosis appears to be safe, with a low rate
of early and late complications in elderly patients at high surgical risk,
with good clinical outcomes at 9 months. Its implementation in the
Republic of Moldova is welcome in the conditions of continuously
ageing population and the prevalence of associated comorbidities
